|
1
|
Tong YQ, Liu B, Zheng HY, Gu J, Liu H, Li
F, Tan BH, Hartman M, Song C and Li Y: MiR-215, an activator of the
CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human
glioma. Oncotarget. 6:25024–25033. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shi R, Wang PY, Li XY, Chen JX, Li Y,
Zhang XZ, Zhang CG, Jiang T, Li WB, Ding W and Cheng SJ: Exosomal
levels of miRNA-21 from cerebrospinal fluids associated with poor
prognosis and tumor recurrence of glioma patients. Oncotarget.
6:26971–26981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han L, Liu D, Li Z, Tian N, Han Z, Wang G,
Fu Y, Guo Z, Zhu Z, Du C and Tian Y: HOXB1 is a tumor suppressor
gene regulated by miR-3175 in glioma. PloS One. 10:e01423872015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johnson DR and Galanis E: Incorporation of
prognostic and predictive factors into glioma clinical trials. Curr
Oncol Rep. 15:56–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bageritz J, Puccio L, Piro RM, Hovestadt
V, Phillips E, Pankert T, Lohr J, Herold-Mende C, Lichter P and
Goidts V: Stem cell characteristics in glioblastoma are maintained
by the ecto-nucleotidase E-NPP1. Cell Death Differ. 21:929–940.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang H and Wang Y: Five miRNAs considered
as molecular targets for predicting neuroglioma. Tumour Biol.
37:1051–1059. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fabbri E, Brognara E, Montagner G,
Ghimenton C, Eccher A, Cantù C, Khalil S, Bezzerri V, Provezza L
and Bianchi N: Regulation of IL-8 gene expression in gliomas by
microRNA miR-93. BMC Cancer. 15:6612015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paranjape T, Heneghan H, Lindner R, Keane
FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C,
Nallur S, et al: A 3′-untranslated region KRAS variant and
triple-negative breast cancer: A case-control and genetic analysis.
Lancet Oncol. 12:377–386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fujii T, Shimada K, Tatsumi Y, Hatakeyama
K, Obayashi C, Fujimoto K and Konishi N: microRNA-145 promotes
differentiation in human urothelial carcinoma through
down-regulation of syndecan-1. BMC Cancer. 15:8182015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hata A and Lieberman J: Dysregulation of
microRNA biogenesis and gene silencing in cancer. Sci Signal.
8:re32015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim M, Kasinski AL and Slack FJ: MicroRNA
therapeutics in preclinical cancer models. Lancet Oncol.
12:319–321. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li R and Li X, Ning S, Ye J, Han L, Kang C
and Li X: Identification of a core miRNA-pathway regulatory network
in glioma by therapeutically targeting miR-181d, miR-21, miR-23b,
β-Catenin, CBP, and STAT3. PloS One. 9:e1019032014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kouri FM, Ritner C and Stegh AH: miRNA-182
and the regulation of the glioblastoma phenotype-toward miRNA-based
precision therapeutics. Cell Cycle. 14:3794–3800. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Ma L, Rao Q, Mao Y, Xin Y, Xu H, Li
C and Wang X: MiR-1271 inhibits ovarian cancer growth by targeting
cyclin G1. Med Sci Monit. 21:3152–3158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiang XJ, Deng J, Liu YW, Wan LY, Feng M,
Chen J and Xiong JP: MiR-1271 inhibits cell proliferation, invasion
and EMT in gastric cancer by targeting FOXQ1. Cell Physiol Biochem.
36:1382–1394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Xu L and Jiang L: miR-1271
promotes non-small-cell lung cancer cell proliferation and invasion
via targeting HOXA5. Biochem Biophys Res Commun. 458:714–719. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang CJ, Yen YH, Hung LY, Wang SH, Pu CM,
Chien HF, Tsai JS, Lee CW, Yen FL and Chen YL: Thalidomide inhibits
fibronectin production in TGF-β1-treated normal and keloid
fibroblasts via inhibition of the p38/Smad3 pathway. Biochem
Pharmacol. 85:1594–1602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng C, Wang YL, Xie C, Sang Y, Li TJ,
Zhang M, Wang R, Zhang Q, Zheng L and Zhuang SM: Identification of
a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling
cascade and its implication in hepatic fibrogenesis. Oncotarget.
6:12224–12233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Shen S, Liao Z, Shi W, Wang Y,
Zhao J, Hu Y, Yang J, Chen J, Mei H, et al: Targeting fibronectins
of glioma extracellular matrix by CLT1 peptide-conjugated
nanoparticles. Biomaterials. 35:4088–4098. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang L, Zhang S, Yao J, Lowery FJ, Zhang
Q, Huang WC, Li P, Li M, Wang X, Zhang C, et al:
Microenvironment-induced PTEN loss by exosomal microRNA primes
brain metastasis outgrowth. Nature. 527:100–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kontomanolis EN and Koukourakis MI:
MicroRNA: The potential regulator of endometrial carcinogenesis.
Microrna. 4:18–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kong D, Zhang G, Ma H and Jiang G:
miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK.
Neoplasma. 62:559–566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jensen KP and Covault J: Human miR-1271 is
a miR-96 paralog with distinct non-conserved brain expression
pattern. Nucleic Acids Res. 39:701–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang M, Shan X, Zhou X, Qiu T, Zhu W, Ding
Y, Shu Y and Liu P: miR-1271 regulates cisplatin resistance of
human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and
BCL2. Anticancer Agents Med Chem. 14:884–891. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maurel M, Jalvy S, Ladeiro Y, Combe C,
Vachet L, Sagliocco F, Bioulac-Sage P, Pitard V, Jacquemin-Sablon
H, Zucman-Rossi J, et al: A functional screening identifies five
microRNAs controlling glypican-3: Role of miR-1271 down-regulation
in hepatocellular carcinoma. Hepatology. 57:195–204. 2013.
View Article : Google Scholar : PubMed/NCBI
|
